These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31706899)

  • 21. Drug-resistant cytomegalovirus: clinical implications of specific mutations.
    Razonable RR
    Curr Opin Organ Transplant; 2018 Aug; 23(4):388-394. PubMed ID: 29794552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis.
    James SH; Prichard MN
    Infect Disord Drug Targets; 2011 Oct; 11(5):504-13. PubMed ID: 21827431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ganciclovir-resistant post-transplant cytomegalovirus infection due to combined deletion mutation at codons 595-596 of the UL97 gene.
    Leung PYM; Tran T; Testro A; Paizis K; Kwong J; Whitlam JB
    Transpl Infect Dis; 2019 Dec; 21(6):e13168. PubMed ID: 31498954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus.
    Allice T; Busca A; Locatelli F; Falda M; Pittaluga F; Ghisetti V
    J Antimicrob Chemother; 2009 Mar; 63(3):600-8. PubMed ID: 19147520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.
    Vinuesa V; Bracho MA; Albert E; Solano C; Torres-Puente M; Giménez E; González-Candelas F; Navarro D
    J Gen Virol; 2017 Oct; 98(10):2530-2542. PubMed ID: 28874227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of cytomegalovirus drug resistance mutations by next-generation sequencing.
    Sahoo MK; Lefterova MI; Yamamoto F; Waggoner JJ; Chou S; Holmes SP; Anderson MW; Pinsky BA
    J Clin Microbiol; 2013 Nov; 51(11):3700-10. PubMed ID: 23985916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.
    Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K
    J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection.
    Mihm J; Leyking S; Dirks J; Smola S; Fliser D; Sester U; Sester M; Wilkens H; Rissland J
    J Clin Virol; 2016 Sep; 82():5-8. PubMed ID: 27389910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
    Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance of human cytomegalovirus to antiviral drugs.
    Erice A
    Clin Microbiol Rev; 1999 Apr; 12(2):286-97. PubMed ID: 10194460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.
    Campos AB; Ribeiro J; Boutolleau D; Sousa H
    Rev Med Virol; 2016 May; 26(3):161-82. PubMed ID: 26990717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of cytomegalovirus populations harbouring mutations in genes UL54 and UL97 in a haematopoietic stem cell transplant recipient.
    Schnepf N; Dhédin N; Mercier-Delarue S; Andreoli A; Mamez AC; Ferry C; Deback C; Ribaud P; Robin M; Socié G; Simon F; Mazeron MC
    J Clin Virol; 2013 Dec; 58(4):733-6. PubMed ID: 24183928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose Valganciclovir Treatment for Resistant Cytomegalovirus Colitis due to UL97 and UL54 Mutations.
    Baradhi KM; Aure RL; El-Amm JM
    Transplant Proc; 2018; 50(1):142-144. PubMed ID: 29407298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients.
    Boivin G; Goyette N; Gilbert C; Roberts N; Macey K; Paya C; Pescovitz MD; Humar A; Dominguez E; Washburn K; Blumberg E; Alexander B; Freeman R; Heaton N; Covington E
    J Infect Dis; 2004 May; 189(9):1615-8. PubMed ID: 15116297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.
    Le Page AK; Jager MM; Iwasenko JM; Scott GM; Alain S; Rawlinson WD
    Clin Infect Dis; 2013 Apr; 56(7):1018-29. PubMed ID: 23243176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of next-generation sequencing to detect mutations associated with antiviral drug resistance in cytomegalovirus.
    Streck NT; Espy MJ; Ferber MJ; Klee EW; Razonable RR; Gonzalez D; Sayada C; Heaton PR; Chou S; Binnicker MJ
    J Clin Microbiol; 2023 Oct; 61(10):e0042923. PubMed ID: 37750719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.
    Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H
    Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.
    Mousavi-Jazi M; Schloss L; Drew WL; Linde A; Miner RC; Harmenberg J; Wahren B; Brytting M
    J Clin Virol; 2001 Dec; 23(1-2):1-15. PubMed ID: 11595579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral-resistant cytomegalovirus infections in solid organ transplantation in the Netherlands.
    Van Leer Buter CC; de Voogd DWK; Blokzijl H; de Joode AAE; Berger SP; Verschuuren EAM; Niesters HGM
    J Antimicrob Chemother; 2019 Aug; 74(8):2370-2376. PubMed ID: 31093660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.